Rentiapril
Изглед
Nazivi | |
---|---|
IUPAC naziv
(2R,4R)-2-(2-hidroksifenil)-3-(3-merkapto-1-oksopropil)-4-tiazolidinekarboksilna kiselina
| |
Identifikacija | |
3D model (Jmol)
|
|
| |
Svojstva | |
C13H15NO4S2 | |
Molarna masa | 313,3925 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
verifikuj (šta je ?) | |
Reference infokutije | |
Rentiapril je ACE inhibitor.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Takase K, Ikuse T, Aono H, Okahara A (1995). „Toxicity study of the angiotensin converting enzyme inhibitor rentiapril in rats”. Arzneimittelforschung. 45 (1): 15—8. PMID 7893262.